Natco Pharma Announcements
The Exchange has sought clarification from Natco Pharma Ltd on January 7, 2026, with reference to news appeared in https://economictimes.indiatimes.com/ dated January 7, 2026 quoting...
07 Jan, 2026 | 11:04am • Source: BSE
Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018
06 Jan, 2026 | 04:32pm • Source: BSE
Sustainability Report for the year 2024-25
05 Jan, 2026 | 05:05pm • Source: BSE
Closure of Trading Window w.e.f. January 1, 2026
29 Dec, 2025 | 12:08pm • Source: BSE
Appointment of Mr. Amit Parekh as Executive Vice President - Finance & Accounts w.e.f. 2nd December, 2025
02 Dec, 2025 | 12:34pm • Source: BSE
Intimation of Credit Rating
29 Nov, 2025 | 09:49am • Source: BSE
Conclusion of USFDA inspection at our Manali, Chennai API unit
21 Nov, 2025 | 04:12pm • Source: BSE
Investor Presentation on the Financial Results for the quarter and half year ended 30th September, 2025
14 Nov, 2025 | 03:07pm • Source: BSE
The Board of Directors approved the 2nd Interim Dividend of Rs.1.50 (75%) per Equity Share of Rs.2/- each for the FY 2025-26
14 Nov, 2025 | 01:46pm • Source: BSE
Outcome of the Board Meeting
14 Nov, 2025 | 01:44pm • Source: BSE
Record Date for payment of 2nd Interim Dividend for the FY 2025-26 is 20th November, 2025
14 Nov, 2025 | 01:37pm • Source: BSE
Outcome of Board Meeting held on 14th November, 2025
14 Nov, 2025 | 01:31pm • Source: BSE
Adcock Ingram Holdings Limited completes delisting from Johannesburg Stock Exchange and Natco Pharma Limited acquires 35.75% stake
12 Nov, 2025 | 03:07pm • Source: BSE
Revised Intimation about earnings call for the quarter and half year ended 30th September 2025
11 Nov, 2025 | 12:53pm • Source: BSE
Q2FY26 Un-audited Financial Results Earnings Call
07 Nov, 2025 | 12:30pm • Source: BSE
Natco Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and...
07 Nov, 2025 | 11:48am • Source: BSE
Natco Pharma Limited has informed the Exchange regarding a press release dated October 31, 2025, titled "NATCO announces launch of its Everolimus tablets, 1 mg,...
31 Oct, 2025 | 09:41am • Source: NSE
NATCO announces the launch of its Everolimus tablets, 1 mg, (generic of Zortress)
31 Oct, 2025 | 09:07am • Source: BSE
Legal update regarding Risdiplam
17 Oct, 2025 | 05:11pm • Source: BSE